Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes Control
Pager-sized monitor for diabetes control receives FDA clearance
July 24th, 2005
Metrika Inc. announced it received marketing clearance from the U.S. Food and Drug Administration (FDA) for the company's new A1cNow INView multi-test system for monitoring hemoglobin A1C, the gold standard indicator of diabetes control. Used in a physician's office or at home, in only 5 minutes the pager-sized monitor provides immediate, lab-quality quantitative A1C test results for determining a person's average blood sugar level over the past 2 or 3 months. The test only requires a 10-microliter whole-blood sample via finger stick to obtain lab-quality results. Studies have shown that a 1% reduction in A1C can lower risk of blindness, amputation, kidney and nerve...
Source: Medical Letter on the CDC & FDA (2005-07-24)
|
